247 related articles for article (PubMed ID: 25031618)
1. Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention.
Poon SL; McPherson JR; Tan P; Teh BT; Rozen SG
Genome Med; 2014; 6(3):24. PubMed ID: 25031618
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair.
Phillips DH
DNA Repair (Amst); 2018 Nov; 71():6-11. PubMed ID: 30236628
[TBL] [Abstract][Full Text] [Related]
3. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
Meier B; Volkova NV; Gerstung M; Gartner A
DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
[TBL] [Abstract][Full Text] [Related]
4. Dissection of Cancer Mutational Signatures with Individual Components of Cigarette Smoking.
Mingard C; Battey JND; Takhaveev V; Blatter K; Hürlimann V; Sierro N; Ivanov NV; Sturla SJ
Chem Res Toxicol; 2023 Apr; 36(4):714-723. PubMed ID: 36976926
[TBL] [Abstract][Full Text] [Related]
5. Signatures of mutational processes in human cancer.
Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR
Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592
[TBL] [Abstract][Full Text] [Related]
6. Geographic variation of mutagenic exposures in kidney cancer genomes.
Senkin S; Moody S; Díaz-Gay M; Abedi-Ardekani B; Cattiaux T; Ferreiro-Iglesias A; Wang J; Fitzgerald S; Kazachkova M; Vangara R; Le AP; Bergstrom EN; Khandekar A; Otlu B; Cheema S; Latimer C; Thomas E; Atkins JR; Smith-Byrne K; Cortez Cardoso Penha R; Carreira C; Chopard P; Gaborieau V; Keski-Rahkonen P; Jones D; Teague JW; Ferlicot S; Asgari M; Sangkhathat S; Attawettayanon W; Świątkowska B; Jarmalaite S; Sabaliauskaite R; Shibata T; Fukagawa A; Mates D; Jinga V; Rascu S; Mijuskovic M; Savic S; Milosavljevic S; Bartlett JMS; Albert M; Phouthavongsy L; Ashton-Prolla P; Botton MR; Silva Neto B; Bezerra SM; Curado MP; Zequi SC; Reis RM; Faria EF; de Menezes NS; Ferrari RS; Banks RE; Vasudev NS; Zaridze D; Mukeriya A; Shangina O; Matveev V; Foretova L; Navratilova M; Holcatova I; Hornakova A; Janout V; Purdue MP; Rothman N; Chanock SJ; Ueland PM; Johansson M; McKay J; Scelo G; Chanudet E; Humphreys L; de Carvalho AC; Perdomo S; Alexandrov LB; Stratton MR; Brennan P
Nature; 2024 May; 629(8013):910-918. PubMed ID: 38693263
[TBL] [Abstract][Full Text] [Related]
7. Mutational and epigenetic signatures in cancer tissue linked to environmental exposures and lifestyle.
Perduca V; Omichessan H; Baglietto L; Severi G
Curr Opin Oncol; 2018 Jan; 30(1):61-67. PubMed ID: 29076965
[TBL] [Abstract][Full Text] [Related]
8. The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time.
Rosendahl Huber A; Van Hoeck A; Van Boxtel R
Front Genet; 2021; 12():760039. PubMed ID: 34745228
[TBL] [Abstract][Full Text] [Related]
9. Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.
Hollstein M; Alexandrov LB; Wild CP; Ardin M; Zavadil J
Oncogene; 2017 Jan; 36(2):158-167. PubMed ID: 27270430
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
Poon SL; Pang ST; McPherson JR; Yu W; Huang KK; Guan P; Weng WH; Siew EY; Liu Y; Heng HL; Chong SC; Gan A; Tay ST; Lim WK; Cutcutache I; Huang D; Ler LD; Nairismägi ML; Lee MH; Chang YH; Yu KJ; Chan-On W; Li BK; Yuan YF; Qian CN; Ng KF; Wu CF; Hsu CL; Bunte RM; Stratton MR; Futreal PA; Sung WK; Chuang CK; Ong CK; Rozen SG; Tan P; Teh BT
Sci Transl Med; 2013 Aug; 5(197):197ra101. PubMed ID: 23926199
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput next-generation sequencing-based method for detecting the mutational fingerprint of carcinogens.
Besaratinia A; Li H; Yoon JI; Zheng A; Gao H; Tommasi S
Nucleic Acids Res; 2012 Aug; 40(15):e116. PubMed ID: 22735701
[TBL] [Abstract][Full Text] [Related]
12. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
[TBL] [Abstract][Full Text] [Related]
13. Influence network model uncovers relations between biological processes and mutational signatures.
Amgalan B; Wojtowicz D; Kim YA; Przytycka TM
Genome Med; 2023 Mar; 15(1):15. PubMed ID: 36879282
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.
Jakobsdottir GM; Brewer DS; Cooper C; Green C; Wedge DC
BMC Biol; 2022 May; 20(1):117. PubMed ID: 35597990
[TBL] [Abstract][Full Text] [Related]
15. Mutation signatures implicate aristolochic acid in bladder cancer development.
Poon SL; Huang MN; Choo Y; McPherson JR; Yu W; Heng HL; Gan A; Myint SS; Siew EY; Ler LD; Ng LG; Weng WH; Chuang CK; Yuen JS; Pang ST; Tan P; Teh BT; Rozen SG
Genome Med; 2015; 7(1):38. PubMed ID: 26015808
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide somatic mutation analysis via Hawk-Seq™ reveals mutation profiles associated with chemical mutagens.
Matsumura S; Sato H; Otsubo Y; Tasaki J; Ikeda N; Morita O
Arch Toxicol; 2019 Sep; 93(9):2689-2701. PubMed ID: 31451845
[TBL] [Abstract][Full Text] [Related]
17. A genome-wide mutation analysis method enabling high-throughput identification of chemical mutagen signatures.
Matsumura S; Fujita Y; Yamane M; Morita O; Honda H
Sci Rep; 2018 Jun; 8(1):9583. PubMed ID: 29942026
[TBL] [Abstract][Full Text] [Related]
18. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
19. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
20. Experimental investigations of carcinogen-induced mutation spectra: Innovation, challenges and future directions.
Melki PN; Korenjak M; Zavadil J
Mutat Res Genet Toxicol Environ Mutagen; 2020 May; 853():503195. PubMed ID: 32522347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
